A cholinesterase inhibitor designed to manage symptoms of dementia in Alzheimer's and Parkinson's and intended to support cognitive function to alleviate memory loss.
Mechanism of Action
It increases the concentration of acetylcholine in the brain by inhibiting the enzymes that break it down. Acetylcholine is essential for memory, learning, and overall thinking.
Route of Administration
Oral
Onset Time
Several weeks
Duration
12–24 hours (depending on form)
Contraindications
Severe liver disease, History of patch-related skin reactions, Allergy to rivastigmine or carbamates
Severe Adverse Events
Gastrointestinal bleeding, Severe skin reactions, Fainting, Worsening of Parkinson's symptoms
Information for Exelon is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
